New depression pill shows early promise in clinical trial
Disease control
Completed
This study tested an experimental oral medication called GM-1020 in people with moderate to severe depression. The main goals were to check if the drug is safe and well-tolerated, and to look for early signs that it might help reduce depression symptoms. The trial involved 46 adu…
Phase: PHASE2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC